Branch retinal vein occlusion: Pathogenesis, visual prognosis, and treatment modalities
DOI 10.1080/02713680701851902, PII 790777372
J. Rehak, and M. Rehak Branch retinal vein occlusion: pathogenesis, visual prognosis, and treatment modalities Curr Eye Res 33 2008 111 131 (Pubitemid 351302200)
A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular edema secondary to branch retinal vein occlusion: The Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) Study report 6
SCORE Study Research Group
SCORE Study Research Group A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular edema secondary to branch retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) Study report 6 Arch Ophthalmol 127 2009 1115 1128
Ranibizumab for macular edema following branch retinal vein occlusion: Six-month primary end point results of a phase III study
BRAVO Investigators
P.A. Campochiaro, J.S. Heier, L. Feiner BRAVO Investigators Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a phase III study Ophthalmology 117 2010 1102 1112
Ranibizumab for macular edema following central retinal vein occlusion: Six-month primary end point results of a phase III study
CRUISE Investigators
D.M. Brown, P.A. Campochiaro, R.P. Singh CRUISE Investigators Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study Ophthalmology 117 2010 1124 1133
A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: The Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) Study report 5
SCORE Study Research Group
SCORE Study Research Group A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) Study report 5 Arch Ophthalmol 127 2009 1101 1114
Randomized controlled study of an intravitreous dexamethasone drug delivery system in patients with persistent macular edema
DOI 10.1001/archopht.125.3.309
B.D. Kuppermann, M.S. Blumenkranz, J.A. Haller Dexamethasone DDS Phase II Study Group Randomized controlled study of an intravitreous dexamethasone drug delivery system in patients with persistent macular edema Arch Ophthalmol 125 2007 309 317 (Pubitemid 46425557)
Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion
OZURDEX GENEVA Study Group
J. Haller, F. Bandello, R. Belfort Jr OZURDEX GENEVA Study Group Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion Ophthalmology 117 2010 1134 1146
Photocoagulation for diabetic macular edema: Early Treatment Diabetic Retinopathy Study report number 1
Early Treatment Diabetic Retinopathy Study Research Group
Early Treatment Diabetic Retinopathy Study Research Group Photocoagulation for diabetic macular edema: Early Treatment Diabetic Retinopathy Study report number 1 Arch Ophthalmol 103 1985 1796 1806